Bartonella henselae (Cat Scratch) Substrate Slide

  • Applications
    • IF
  • Code # BH-1606
  • Size 6 wells
  • Price Call for Price
Specifications

Background

The Bartonella bacillus is a delicate, fastidious, slow-growing, aerobic, gram negative, pleomorphic rod. Members of the genus Bartonella have recently been associated with an increasing spectrum of diverse clinical syndromes ranging from only lymphadenopathy, in cat scratch disease (CSD), to systemic disease including bacillary angiomatosis (BA). Serious complications can include endocardi- tis and lesions of almost every organ system including the heart, liver, spleen, bone and bone marrow, lymphatics, muscle and soft tissue, and the central nervous system. Cat Scratch Disease (CSD) is a persistent, necrotizing inflammation of the lymph nodes affecting an estimated 24,000 persons annually. CSD occurs primarily in children and young adults usually less than 21 years of age. CSD is seasonal, with most cases predominantly in the fall and winter. This may be accounted for by having cats indoors in these seasons. The role of cats in the transmission of the agent causing CSD is well established. A patient with a history of cat contact or scratch presents with lymphadenopathy usually preceded by an erythematous papule at the inoculation site. Uncomplicated CSD usually resolves spontaneously in 2-6 months. Less often, (5-20%) patients may experience rash, hepatosplenomegaly, lytic bone lesions, granulomatous conjunctivitis, pneumonitis, endocarditis, and central nervous system involvement.

  • Application:
    IF
  • Components:

    MBL Bion BARTONELLA ANTIGEN SUBSTRATE SLIDES are individually foil-wrapped six well slides with a mixture of B. henselae (Houston strain) infected and uninfected HEp-2 cells fixed onto each well. Each well contains an average of 25-30% infected cells per 200X field.

  • Description:

    The MBL Bion BARTONELLA HENSELAE ANTIGEN SUBSTRATE SLIDES may be utilized in the indirect fluorescent antibody assay method. Each lot is tested with a panel of titered sera to ensure sensitivity lot to lot; both positive and negative cells are in each well to provide a built-in control.

    For Research Use Only

  • Product Type:
    Antigen Substrate Slide
  • Research Area:
    Infectious Disease
  • Short Description:

    For Research Use Only

  • Size:
    6 wells
References
  1. Anderson, B.E., and M.A. Neuman. Bartonella spp. as Emerging Human Pathogens. Clin. Micro. Rev., 10:203-219, 1997.
  2. Drancourt, M., J.L. Mainardi, et.al. Bartonella (Rochalimaea) quintana endocarditis in three Homeless Men, N. Eng. J. Med., 332:419-423, 1995 
  3. Spach, D.H., K.P. Callis, et.al. Endocarditis Caused by Rochalimaea quintana in a Patient Infected with Human Immunodeficiency Virus, J. Clin. Micro. 34:692-694, 1993.
  4. Spach, D.H., A.S. Kanter, et.al. Bartonella (Rochalimaea) quintana Bacteremia in Inner-city Patients with Chronic Alcoholism, N. Eng. J. Med. 332:424-428, 1995.
  5. Daly, J.S., M.G. Worthington, et.al. Rochalimaea elizabethae sp. nov. Isolated From a Patient with Endocarditis, J. Clin. Micro. 31:872-881, 1993.
  6. Slater, L.N., D.F. Welch, D. Hensel, and D.W. Coody. A newly Recognized Fastidious Gram-negative Pathogen as a Cause of Fever and Bacteremia, N. Eng. J. Med. 23:1587-1593, 1990.
  7. Angritt, P., S.M. Tuur, et.al. Epithelioid Angimatosis in HIV Infection; Neoplasm or Cat-scratch Disease? Lancet 1:996, 1988.
  8. Hall, A.V., C.M. Roberts, P.D. Maurice, K.A. McLean, and S. Shousha. Cat-scratch Disease in Patients with AIDS; Atypical Skin manifestations, lancet ii:453-454, 1988.
  9. Margileth, A.M., D.J. Wear, and C.K. English. Systemic Cat-Scratch Disease: Report of 23 Patients with Prolonged or Recurrent Severe Bacterial Infection, J. Infect. Dis. 155:390402, 1987.
  10. Carithers, H.A., C.M. Carithers, and R.O. Edwards. Cat-scratch Disease, Its Natural History. JAMA 207:312-316, 1969.
  11. Weller, T.H., A.H. Coons, Fluorescent Antibody Studies with Agents of Varicella and Herpes Zoster Propagated in Vitro, Proc. Soc. Exp. Biol. Med., 86:789-794, 1954.
  12. Riggs, J.L., R.J. Siewald, J.H. Burckhalter, C.M. Downs, T.G. Metcalf, Isothiocyanate Compounds as Fluorescent Labeling Agents for Immune Serum. Am. J. Pathol. 34:1081-1097, 1958.
  13. Goldman, M., Fluorescent Antibody Methods. New York, Academic Press, 1968.
  14. Kawamura, A. Jr., Fluorescent Antibody Techniques and Their Application. Baltimore, University Park Press, 1969.
  15. Nairn, R.C., Fluorescent Protein Tracing, Baltimore, Williams and Wilkins, 3rd Ed., 1969.
  16. Johnson, R.B., and R. Libby, Separation of Immunoglobulin M (IgM) Essentially Free of IgG From Serum in Systems Requiring Assay of IgM-Type Antibodies Without Interference From Rheumatoid Factor. J. Clin. Micro. 12:451-454, 1980.
  17. Gispen, R., J. Nagel, B. Brand-Saathof, S. DeGraff, Immunofluorescence Test for IgM Rubella Antibodies in Whole Serum After Absorption with Specific Anti-gamma Fc. Clin. Exp. Immunol., 22:431-437, 1975.
  18. Joassin, L., M. Reginster, Elimination of Nonspecific Cytomegalovirus Immunoglobulin M Activities in the Enzyme-Linked Immunosorbent Assay by Using Antihuman Immunoglobulin G. J. Clin. Microbiol. 23:576-581, 1986.
  19. Lyerla, H.C., F.T. Forrester, The Immunofluorescence (IF) Test, in: Immunofluorescence Methods in Virology, USDHHS, Georgia, 71-81, 1979.
  20. Holborow, E.J., D.M. Weir, G.D. Johnson, A Serum Factor in Lupus Erythematosus With Affinity for Tissue Nuclei, Br. Med. J., 11:732-734, 1957.
  21. Berg, P.A., I. Roitt, D. Doniach, H.M. Cooper, Mitochondrial Antibodies in Primary Biliary Cirrhosis, Immunol. 17:281-293, 1969.
  22. Schmidt, N.J., Update on Class-specific Viral Antibody Assays, Clinical Immunology Newsletter, 4(6):81-85, June, 1984.
  23. Chernesky, M.A., C.G. Ray, T.F. Smith, Laboratory Diagnosis of Viral Infections, Cumitech 15, ASM, Washington, D.C., March 1982.
  24. Gardner, P.S., J. McQuillin, Rapid Virus Diagnosis: Application of Immunofluorescence, In: Detection of Virus Specific IgM by Immunofluorescence, Butterworth, Boston, 259-287, 1980.
  25. Data on file, MBL Bion, Des Plaines, IL.
  26. Patnaik, M., W.A. Schwartzman, N.E. Barka, and J.B. Peter. (Letter) Lancet 340:971, 1992.
  27. Zangwill, K.M., D.H. Hamilton, et.al. Cat Scratch Disease in Connecticut; Epidemiology, Risk Factors and Evaluation of a New Diagnostic Test, N. Eng. J. Med. 329:8-13, 1993.
  28. Anderson, B., K. Sims, R. Regnery, et.al. Detection of Rochalimaea henselae DNA in Specimens from Cat Scratch Disease Patients by PCR, J. Clin. Micro. 32:942-948, 1994.
  29. Dalton, M.J., L.E. Robinson, et.al. Use of Bartonella Antigens for Serologic Diagnosis of Cat Scratch Disease at a National Reference Center, Arch. Int. Med. 155:1670-1676, 1995.